8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine
Star0
Identification
- Generic Name
- 8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine
- DrugBank Accession Number
- DB03093
- Background
Not Available
- Type
- Small Molecule
- Groups
- Experimental
- Structure
- Weight
- Average: 303.2917
Monoisotopic: 303.113152922 - Chemical Formula
- C14H14FN5O2
- Synonyms
- Not Available
Pharmacology
- Indication
Not Available
Reduce drug development failure ratesBuild, train, & validate machine-learning modelswith evidence-based and structured datasets.Build, train, & validate predictive machine-learning models with structured datasets.- Contraindications & Blackbox Warnings
- Prevent Adverse Drug Events TodayTap into our Clinical API for life-saving information on contraindications & blackbox warnings, population restrictions, harmful risks, & more.Avoid life-threatening adverse drug events with our Clinical API
- Pharmacodynamics
Not Available
- Mechanism of action
Target Actions Organism UHeat shock protein HSP 90-alpha Not Available Humans - Absorption
Not Available
- Volume of distribution
Not Available
- Protein binding
Not Available
- Metabolism
- Not Available
- Route of elimination
Not Available
- Half-life
Not Available
- Clearance
Not Available
- Adverse Effects
- Improve decision support & research outcomesWith structured adverse effects data, including: blackbox warnings, adverse reactions, warning & precautions, & incidence rates. View sample adverse effects data in our new Data Library!Improve decision support & research outcomes with our structured adverse effects data.
- Toxicity
Not Available
- Pathways
- Not Available
- Pharmacogenomic Effects/ADRs
- Not Available
Interactions
- Drug Interactions
- This information should not be interpreted without the help of a healthcare provider. If you believe you are experiencing an interaction, contact a healthcare provider immediately. The absence of an interaction does not necessarily mean no interactions exist.Not Available
- Food Interactions
- Not Available
Categories
- Drug Categories
- Not Available
- Chemical TaxonomyProvided by Classyfire
- Description
- This compound belongs to the class of organic compounds known as 6-aminopurines. These are purines that carry an amino group at position 6. Purine is a bicyclic aromatic compound made up of a pyrimidine ring fused to an imidazole ring.
- Kingdom
- Organic compounds
- Super Class
- Organoheterocyclic compounds
- Class
- Imidazopyrimidines
- Sub Class
- Purines and purine derivatives
- Direct Parent
- 6-aminopurines
- Alternative Parents
- Dimethoxybenzenes / Phenoxy compounds / Anisoles / Aminopyrimidines and derivatives / Alkyl aryl ethers / 2-halopyrimidines / Imidolactams / Aryl fluorides / Imidazoles / Heteroaromatic compounds show 5 more
- Substituents
- 2-halopyrimidine / 6-aminopurine / Alkyl aryl ether / Amine / Aminopyrimidine / Anisole / Aromatic heteropolycyclic compound / Aryl fluoride / Aryl halide / Azacycle show 23 more
- Molecular Framework
- Aromatic heteropolycyclic compounds
- External Descriptors
- Not Available
- Affected organisms
- Not Available
Chemical Identifiers
- UNII
- Not Available
- CAS number
- Not Available
- InChI Key
- MWHAHELTVGJGFJ-UHFFFAOYSA-N
- InChI
- InChI=1S/C14H14FN5O2/c1-21-8-3-4-9(22-2)7(5-8)6-10-17-11-12(16)19-14(15)20-13(11)18-10/h3-5H,6H2,1-2H3,(H3,16,17,18,19,20)
- IUPAC Name
- 8-[(2,5-dimethoxyphenyl)methyl]-2-fluoro-7H-purin-6-amine
- SMILES
- COC1=CC(CC2=NC3=NC(F)=NC(N)=C3N2)=C(OC)C=C1
References
- General References
- Not Available
- External Links
- PubChem Compound
- 448973
- PubChem Substance
- 46507104
- ChemSpider
- 395621
- BindingDB
- 15382
- ChEMBL
- CHEMBL324951
- ZINC
- ZINC000003833893
- PDBe Ligand
- PU2
- PDB Entries
- 1uyg
Clinical Trials
Pharmacoeconomics
- Manufacturers
- Not Available
- Packagers
- Not Available
- Dosage Forms
- Not Available
- Prices
- Not Available
- Patents
- Not Available
Properties
- State
- Solid
- Experimental Properties
- Not Available
- Predicted Properties
Property Value Source Water Solubility 0.173 mg/mL ALOGPS logP 2.32 ALOGPS logP 1.69 Chemaxon logS -3.2 ALOGPS pKa (Strongest Acidic) 10.3 Chemaxon pKa (Strongest Basic) 1.93 Chemaxon Physiological Charge 0 Chemaxon Hydrogen Acceptor Count 6 Chemaxon Hydrogen Donor Count 2 Chemaxon Polar Surface Area 98.94 Å2 Chemaxon Rotatable Bond Count 4 Chemaxon Refractivity 81.17 m3·mol-1 Chemaxon Polarizability 29.13 Å3 Chemaxon Number of Rings 3 Chemaxon Bioavailability 1 Chemaxon Rule of Five Yes Chemaxon Ghose Filter Yes Chemaxon Veber's Rule No Chemaxon MDDR-like Rule No Chemaxon - Predicted ADMET Features
Property Value Probability Human Intestinal Absorption + 0.9954 Blood Brain Barrier + 0.9224 Caco-2 permeable + 0.5 P-glycoprotein substrate Substrate 0.6149 P-glycoprotein inhibitor I Non-inhibitor 0.7839 P-glycoprotein inhibitor II Non-inhibitor 0.826 Renal organic cation transporter Non-inhibitor 0.7722 CYP450 2C9 substrate Non-substrate 0.9095 CYP450 2D6 substrate Non-substrate 0.7698 CYP450 3A4 substrate Substrate 0.5572 CYP450 1A2 substrate Inhibitor 0.7996 CYP450 2C9 inhibitor Non-inhibitor 0.6863 CYP450 2D6 inhibitor Inhibitor 0.5932 CYP450 2C19 inhibitor Inhibitor 0.6248 CYP450 3A4 inhibitor Inhibitor 0.5966 CYP450 inhibitory promiscuity High CYP Inhibitory Promiscuity 0.7769 Ames test AMES toxic 0.5819 Carcinogenicity Non-carcinogens 0.9 Biodegradation Not ready biodegradable 1.0 Rat acute toxicity 2.7989 LD50, mol/kg Not applicable hERG inhibition (predictor I) Weak inhibitor 0.7731 hERG inhibition (predictor II) Non-inhibitor 0.554
Spectra
- Mass Spec (NIST)
- Not Available
- Spectra
Spectrum Spectrum Type Splash Key Predicted GC-MS Spectrum - GC-MS Predicted GC-MS splash10-0umr-0490000000-bfdc60c38bdaddcc0efe Predicted MS/MS Spectrum - 10V, Positive (Annotated) Predicted LC-MS/MS splash10-0udi-0009000000-98dd498b0a1d55f6c268 Predicted MS/MS Spectrum - 10V, Negative (Annotated) Predicted LC-MS/MS splash10-0udi-0109000000-eafd130dd6ff99844f3e Predicted MS/MS Spectrum - 20V, Positive (Annotated) Predicted LC-MS/MS splash10-0udi-0049000000-8b82aea305bf006d6854 Predicted MS/MS Spectrum - 20V, Negative (Annotated) Predicted LC-MS/MS splash10-0uk9-0092000000-e1ccf12b5486ed32f523 Predicted MS/MS Spectrum - 40V, Positive (Annotated) Predicted LC-MS/MS splash10-0006-0590000000-784b531c22bb38a123f3 Predicted MS/MS Spectrum - 40V, Negative (Annotated) Predicted LC-MS/MS splash10-0a4i-0950000000-e80397c4184119a737f0 Predicted 1H NMR Spectrum 1D NMR Not Applicable Predicted 13C NMR Spectrum 1D NMR Not Applicable - Chromatographic Properties
Collision Cross Sections (CCS)
Adduct CCS Value (Å2) Source type Source [M-H]- 173.04587 predictedDeepCCS 1.0 (2019) [M+H]+ 175.40388 predictedDeepCCS 1.0 (2019) [M+Na]+ 181.49702 predictedDeepCCS 1.0 (2019)
Targets
Build, predict & validate machine-learning models
Use our structured and evidence-based datasets to unlock newinsights and accelerate drug research.
Use our structured and evidence-based datasets to unlock new insights and accelerate drug research.
1. DetailsHeat shock protein HSP 90-alpha
- Kind
- Protein
- Organism
- Humans
- Pharmacological action
- Unknown
- General Function
- Tpr domain binding
- Specific Function
- Molecular chaperone that promotes the maturation, structural maintenance and proper regulation of specific target proteins involved for instance in cell cycle control and signal transduction. Under...
- Gene Name
- HSP90AA1
- Uniprot ID
- P07900
- Uniprot Name
- Heat shock protein HSP 90-alpha
- Molecular Weight
- 84659.015 Da
References
- Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42. [Article]
Drug created at June 13, 2005 13:24 / Updated at June 12, 2020 16:52